No Detail Found!

Clinical Outcomes of De nitive Radiotherapy Delivered by Helical Tomotherapy

Author(s)
Fatima Shaukat Department of Radiation Oncology, CyberKnife and Tomotherapy Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Yumna Ahmed Department of Radiation Oncology, CyberKnife and Tomotherapy Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Rabia Tahseen Department of Radiation Oncology, CyberKnife and Tomotherapy Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Tariq Mahmood Department of Radiation Oncology, CyberKnife and Tomotherapy Centre, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Abstract
Objective: To assess the disease response and patient survival outcomes for cancer patients treated with helical tomotherapy. Study Design: Descriptive study. Place and Duration of the Study: The Tomotherapy Unit of Jinnah Postgraduate Medical Centre, Karachi, Pakistan, from October 2020 to August 2023. Methodology: A retrospective analysis was conducted on the data of patients who underwent de nitive radiation Tomotherapy Centre. The evaluation of disease response utilised CT scans performed three months after completing radiotherapy, following RECIST criteria. Survival and disease-free status were determined through telephonic interviews with the patients. Results: A total of 654 patients received treatment on Tomotherapy, of which, 143 underwent de nitive Radiotherapy. The average age was 51 ± 16.8 years, with 85 (59.4%) males. The predominant area subjected to de nitive radiation was the head and neck, accounting for 65 cases (45.5%), trailed by the gastrointestinal tract and pelvis with 52 (36.4%) and 26 (18.2%) cases, respectively. Response assessment revealed a complete response in 73 (52.14%) patients, partial response in 47 (33.5%), stable disease in 11 (7.85%), and progressive disease in 9 (6.4%). Currently, 108 (77%) patients are alive. Twenty-eight (20%) patients experienced local or distant disease development. Among them, 6 (4.3%) patients had local recurrence, and 22 (15.7%) developed metastatic disease. Conclusion: Helical tomotherapy o ers promising disease control and survival outcomes, making it a viable treatment modality for cancer patients in a lower middle-income country. These ndings highlight the importance of careful patient selection and optimising resource utilisation for curative treatments to enhance cancer care in Pakistan.
Publication Details
Page(s) 66-70
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Radiotherapy, Multidisciplinary Treatment, Peer-review practice, Radiotherapy technique, Tomotherapy
References
Kodaira T,Nishimura Y,Kagami Y,Ito Y,Shikama N,Ishikura S .2015 .De nitive radiotherapy for head and neck squamous cell carcinoma: Update and perspectives on the basis of EBM. Jpn J Clin Oncol, 10(3) : 235-43.
Kataria T,Gupta D,Goyal S,Bisht SS,Basu T,Abhishek A .2016 .Clinical outcomes of adaptive radiotherapy in head and neck cancers. Br J Radiol, 10(1062) : 20160085.
Ariga T,Toita T,Kato S,Kazumoto T,Kubozono M,Tokumaru S .2015 .Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with de nitive radiotherapy: A multi-institutional retrospective research study. J Radiation Res, 10(5) : 841-8.
Herr DJ,Elliott DA,Duchesne G,Stensland KD,Caram ME,Chapman C .2023 .de nitive radiation therapy for localised prostate cancer in a national health care delivery system. Cancer, 10(20) : 3326-33.
Welsh JS,Patel RR,Ritter MA,Harari PM,Mackie TR,Mehta MP .2002 .Helical tomotherapy: An innovative technology and approach to radiation therapy. Technol Cancer Res Treat, 10(4) : 311-6.
Beavis AW .2004 .. Is tomotherapy the future of IMRT? Br J Radiol, 10(916) : 285-95.
Detorie NA .2007 .Helical tomotherapy: A new tool for radiation therapy. J Am Coll Radiol, 09(1) : 63-6.
Cox JD,Stetz J,Pajak TF .1995 .RTOG and the EORTC. Int J Radiat Oncol Biol Phys, 10(95) : 00060-3016.
Adeel M,Faisal M,Rashid A,Rasheed S,Hussain R,Malik KI .2019 .de nitive radiotherapy for laryngeal cancer in terms of survival and patterns of failure. J Laryngol Otol, 10(12) : 1087-91.
Tufail M,Wu C .2023 .7:e2200142. JCO Clin Cancer Inform, 10 : .
Ali A,Manzoor MF,Ahmad N,Aadil RM,Qin H,Siddique R .2022 .The burden of cancer, government strategic policies, and challenges in Pakistan: A comprehensive review. Front Nutr, 940514 : 940514.
Dirix P,Nuyts S .2006 .Radiation-induced xerostomia in patients with head and neck cancer: A literature review. Cancer, 10(11) : 2525-34.
Lee N,Xia P,Fischbein NJ,Akazawa P,Akazawa C,Quivey JM . .Intensity-modulated radiation therapy for head-andneck cancer: The UCSF experience focusing on target. , : .
Bortfeld T. IMRT .2006 .A review and preview. Phys Med Biol, 10(13) : 0031.
Jain N,Jain S,Sharma R,Sachdeva K,Kaur A,Rakesh A .2022 .Intensity-modulated radiotherapy in locally advanced head-and-neck cancers in elderly patients. J Cancer Res Ther, 30(Suppl) : 20-9.
Gestel DV,Weyngaert DVD,Kerf GD,Ost BD,Vanderveken O,Laer CV .2015 .Helical tomotherapy in head and neck cancer: A european single-center experience. Oncologist, 0337(3) : 279-90.
De Felice F,Belgioia L,Alterio D,Bonomo P,Maddalo M,Paiar F .2021 .Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian association of radiotherapy and clinical oncology (AIRO). Crit Rev Oncol Hematol, 103345 : 103345.
Mo HL,Li J,Yang X,Zhang F,Xiong JW,Yang ZL .2017 .Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: A systematic review and meta-analysis. Lasers Med Sci, 10(2) : 461-7.
Eisenhauer EA,Therasse P,Bogaerts J,Sargent D,Ford R,Dancey J .2008 .New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer, 10(2) : 228-47.
Luo HC,Cheng HH,Lin GS,Fu ZC,Li DS .2013 .Intensitymodulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: Long-term outcome of Chinese patients. Asian Pac J Cancer Prev, 14(8) : 4711-5.
Cozzi S,Ruggieri MP,Ali E,Ghersi SF,Vigo F,Augugliaro M .2023 .Moderately hypofractionated helical tomotherapy for prostate cancer: Ten-year experience of a monoinstitutional series of 415 patients. In Vivo, 10(2) : 777-85.
De Bari B,Franzetti-Pellanda A,Saidi A,Biggiogero M,Hahnloser D,Montemurro M .2019 .Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: E cacy and safety in a large, multi-institutional serieJs. Cancer Res Clin Oncol, 10(4) : 1075-84.
Shaukat F,Siddiqui T,Ahmed Y,Khan M,Fahim M,Noor A .2024 .l Assessing the e ectiveness of tumour education among medical students: A pre-post-test analysis. Ecanmedsci, 1727 : 1727.
0

Citations

0

Downloads

84

Views